Company overview
Vizgen provides innovative spatial biology platforms including the MERSCOPE and MERSCOPE Ultra for high-resolution single-cell spatial transcriptomics and multi-omics analysis. They offer InSituPlex multiplex immunofluorescence assays for spatial proteomics, along with assay development services and end-to-end spatial omics services from sample prep to data analysis. Through their Certified Service Provider program and global distributors, Vizgen expands access to these technologies for life sciences and pharmaceutical research.
Vizgen is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include spatial transcriptomics, merscope platform, spatial proteomics, insituplex assays, spatial multi-omics.
Products and technologies associated with Vizgen include Assay — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://vizgen.com/
- Markets served
- United States & Americas
- Keywords
- spatial transcriptomics, merscope platform, spatial proteomics, insituplex assays, spatial multi-omics
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What spatial biology platforms does Vizgen offer?
- Vizgen offers the MERSCOPE and MERSCOPE Ultra platforms for high-resolution in situ spatial transcriptomics, enabling analysis of up to 500 gene targets with single-cell precision, alongside InSituPlex for multiplex immunofluorescence proteomics.
- What services are available for spatial omics research?
- Vizgen provides end-to-end spatial omics services including sample preparation, MERFISH 2.0, InSituPlex assays, and STARVUE analysis, delivering reproducible RNA/protein data and reports via Certified Service Providers.
- What are Vizgen's geographic coverage and distribution options?
- Vizgen has direct sales/support in the UK, BENELUX, Nordics, France, Germany, Austria, and Singapore, with distributors worldwide and a global Certified Service Provider network for broader access.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
